Yoon replaces 6 ministers ahead of his 3rd year, general election
US deploys fighter jets in S. Korea for air exercise in Singapore
S. Korea's economy grows 0.6% in Q3, unchanged from earlier estimate
[Hello Hangeul] Inside the Korean language classroom in Madrid
S. Korea successfully tests solid-fuel space rocket
Celltrion establishes R&D office in BostonBy Kan Hyeong-woo
Published : Aug. 22, 2022 - 15:43
According to company officials, the South Korean biopharmaceutical giant completed the establishment of the Boston office earlier this year. The new US office has been exploring the biotechnology industry’s trends while gathering information on startups and pipelines with investment potential.
Boston is regarded as one of the biggest biotech clusters in the world, as the city is home to global drugmakers’ offices, R&D centers and biotech venture startups along with major schools such as the Massachusetts Institute of Technology and Harvard University.
“The setup (of the Boston office) was completed in the first half of this year and it began local activities. The office has been conducting research and carrying out deal sourcing to identify investment opportunities on biotechnology startups,” a Celltrion official said.
Korea unveils plan to tackle ailing mental health
[KH Explains] China ups OLED ante to take over Korean shares
6 outgoing ministers ‘strong candidates’ for general elections: ruling party